About Us
About Us
  • Board Of Directors
  • Collaborators
  • Staff Directory
  • Job Openings
Our Legacy
Our Legacy
  • Achievements
  • History
  • Irene Diamond
  • Photo Gallery
Current Research
Current Research
  • Our Scientists and Labs
    • Paul Bieniasz
    • Cecilia Cheng-Mayer
    • Theodora Hatziioannou
    • David D. Ho
    • Yaoxing Huang
    • Martin Markowitz
    • Moriya Tsuji
  • Core Facilities
    • Personnel
    • Flow Cytometry
    • Microscope Imaging Facility
Clinical Trials
Clinical Trials
  • HIV+
    • Newly Infected With HIV
    • Living With HIV
    • Physicians
    • FAQ's
  • HIV.
    • Healthy Volunteer
    • FAQ's
Focus On HIV
Focus On HIV
  • Facts About HIV and AIDS
  • HIV Biology
    • The HIV Virus Particle
    • The HIV Replication Cycle
Giving Center
Giving Center
  • Online Giving
  • Other Giving Opportunities
  • Financial Summary
News Center
News Center
  • ADARC In The News
  • Seminars
  • Newsletters and Brochures
  • For Journalists
China Aids Initiative
China Aids Initiative
Multimedia Library
Multimedia Library
Talks at ADARC
Talks at ADARC
ADARC Gala
ADARC Gala
  • Gala video
  • Gala photo
  • leadership committee
  • Online Giving
Register for Updates
Register for Updates
Clinical Trails

Newly Infected


If You Think You Have Been Newly Infected with HIV

If you have been newly infected with HIV, you may be eligible to participate in one of our clinical trials with The Aaron Diamond AIDS Research Center Primary Infection Program. Primary infection refers to a newly-established HIV infection. We are interested in seeing people who are within 6 months of contracting HIV. Please click the links below for more information about our open trials. Also, be sure to check out the Frequently Asked Questions section to learn more about being newly infected with HIV and participating in a trial with the Aaron Diamond AIDS Research Center. If you are interested in participating, please contact Melissa La Marat 212-327-7280 or e-mail her at mlamar@adarc.org.


Clinical Trials for Acutely Infected Patients



(MMA-0448)
Viral and Host factors in the transmission and pathogenesis of HIV
The reason for doing this research is to study viral and host factors involved in the transmission and pathogenesis (the course of an illness or condition, from its origin to manifestation and outbreak) of HIV infection.

(MMA-0559)
The Role of the Gastrointes-
tinal Lymphoid System in the Pathogenesis of HIV 1 Infection and Health
The reason for doing this research is to determine which cells in the gastrointestinal tract are infected with HIV, if the number of HIV-infected cells in the gastrointestinal tract are greater than in the blood and to assess the response of immune cells in the intestines towards the HIV virus.

(MMA-0606)
Mucosal and Innate Immune Responses and Viral Reservoirs in Tissues and Cells During Acute HIV Infection, Version 4.0 (CHAVI-012)
The reason for doing this research is to understand how people’s infection fighting (immune) system reacts to the Human Immunodeficiency Virus (HIV), particularly in tissues from the body. We wanted to understand how the human body responds to HIV.

(MMA-0639)
Acute HIV-1 Infection Prospective Cohort Stud
Rockefeller University is part of a group of scientists from all over the world doing research on how HIV works in the body. It is hoped that this research will help to make medicines to prevent the spread of HIV. HIV is the virus that causes AIDS. The purpose of this research study is to understand how people's infection fighting (immune) system reacts to HIV.
((MMA-0776)
Immune Activation HIV Positive IDU)
The goal of this study is to learn how injecting drugs may affect the immune system of people who are infected with HIV-1. The reason for doing this research is to determine how injecting drugs can affect the response to HIV treatments in HIV-positive people.